Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK)

Urokinase-type plasminogen activator (uPA) is associated with cancer recurrence where the most evidence comes from studies in breast cancer. According to the European Organization for Research and Treatment of Cancer, uPA is considered one of the most prominent biomarkers for cancer recurrence and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Nancy Dos, Habibi, Golareh, Wang, Michelle, Law, Jennifer H., Andrews, Heather N., Wei, Daniel, Triche, Timothy, Dedhar, Shoukat, Dunn, Sandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2007
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634623/
https://www.ncbi.nlm.nih.gov/pubmed/23645983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634623/
https://www.ncbi.nlm.nih.gov/pubmed/23645983

Ejemplares similares